Sources: OpenAI is pitching investors on a possible share sale that would value the AI startup at between $80B and $90B, almost triple its level earlier in 2023
Context & Ripple Effects
OpenAI had reportedly been valued at $20 billion in a secondary sale while projecting $200 million in 2023 revenue and $1 billion by 2024. This proposed $80 billion-to-$90 billion share-sale range would sharply reset the market’s reference price for the company.
The report also foreshadows the valuation level later formalized in an $80 billion-plus deal with an employee tender offer, making this an early marker of investor demand for exposure to a frontier AI lab.
First-order effects
- A share sale at the proposed range would give OpenAI and its holders a much higher private-market valuation benchmark, nearly tripling the level reported earlier in 2023.
- Investors considering the transaction would be pricing OpenAI against its stated growth ambitions, including the revenue targets it had shared with investors.
Second-order effects
- A higher benchmark can make subsequent fundraising and secondary transactions easier to structure, while raising the price that new investors must accept for access to OpenAI equity.
- Other AI companies seeking private capital would face a clearer comparison point, increasing pressure to demonstrate either comparable commercial traction or a differentiated technical position.
Third-order effects
- If repeated, such repricing concentrates private AI financing in a small set of labs able to command large valuations before public listings, with secondary markets becoming an important liquidity channel.
- The pattern points toward later secondary-sale discussions at far higher valuations: private-market price discovery may increasingly shape who can fund and retain talent at leading AI developers.
The trend: This is an early example of frontier-lab capital concentration, in which scarce access to leading AI companies drives ever-larger private valuation steps.